Newest pathogenetic considerations in inclusion-body myositis: possible role of amyloid-beta, cholesterol, relation to aging and to Alzheimer's disease.

被引:13
作者
Askanas V. [1 ]
Engel W.K. [1 ]
机构
[1] University of Southern California Neuromuscular Center, Good Samaritan Hospital, 637 South Lucas Avenue, Los Angeles, 90017-1912, CA
关键词
Myositis; Inflammatory Muscle Disease; Pathogenetic Consideration; Vacuolated Muscle Fiber; Abnormal Muscle Fiber;
D O I
10.1007/s11926-002-0088-8
中图分类号
学科分类号
摘要
This report summarizes clinical features and diagnostic criteria, and the newest advances related to seeking the pathogenic mechanism(s) of sporadic inclusion-body myositis. On the basis of the authors' research, several processes seem to be important in relation to the still-speculative pathogenesis: increased transcription and accumulation of amyloid-b precursor protein and accumulation of its proteolytic fragment amyloid-b; abnormal accumulation of components related to lipid metabolism (eg, low-density lipoprotein receptors and cholesterol; accumulation of cholesterol is possibly caused by its abnormal trafficking); oxidative stress; accumulations of other Alzheimer-related proteins including phosphorylated tau; a milieu of muscle cellular aging in which these changes occur. The authors' basic hypothesis is that overexpression of amyloid-b precursor protein within the aging muscle fibers is an early upstream event causing the subsequent pathogenic cascade. The remarkable pathologic similarities between inclusion-body myositis muscle and Alzheimer's disease brain are discussed.
引用
收藏
页码:427 / 433
页数:6
相关论文
共 136 条
[1]  
Askanas V(2001)Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease J Neuropathol Exp Neurol 60 1-14
[2]  
Engel WK(2001)Inclusion body myositis: genetic factors, aberrant protein expression, and autoimmunity Curr Opin Rheumatol 13 469-475
[3]  
Oldfors A(1993)New advances in inclusion-body myositis Curr Opin Rheumatol 5 732-741
[4]  
Fyhr IM(2001)Patterns of muscle involvement in inclusion body myositis: clinical and magnetic resonance imaging study Muscle Nerve 24 1526-1534
[5]  
Askanas V(2000)Late-juvenile sporadic inclusion body myositis: a newly recognized syndrome Ann Neurol 48 439-440
[6]  
Engel WK(2000)Inclusion body myositis, muscle blood vessel and cardiac amyloidosis, and transthyretin Vall22Ile Allele Ann Neurol 47 544-549
[7]  
Phillips BA(1997)Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans N Engl J Med 336 466-473
[8]  
Cala LA(1997)Sporadic inclusionbody myositis (s-IBM) in an HTLV-I-positive Iranian Muslim Neurology 48 124-124
[9]  
Thickbroom GW(2001)Sporadic inclusion body myositis in a patient with human T cell leukemia virus type 1-associated myelopathy Clin Infect Dis 32 510-514
[10]  
Askanas V(1996)Inclusion body myositis in HIV -1 and HTLV-1 infected patients Brain 119 1887-1893